Turn Therapeutics Inc. Company Profile
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:38 AM ET
Turn Therapeutics at a glance
Turn Therapeutics Inc. (NASDAQ: TTRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Westlake Village, CA. Turn Therapeutics is led by Mr. Bradley E. Burnam and employs about 2 people. At a market capitalization of $345.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002023016, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Turn Therapeutics do?
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Business description based on the company's public filings.
Company information
- Legal name
- Turn Therapeutics Inc.
- Ticker
- NASDAQ: TTRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Bradley E. Burnam
- Employees
- 2
- Headquarters
- 250 N Westlake Blvd, Westlake Village, CA, United States
- Phone
- 818 546 4011
- Website
- turntherapeutics.com
- Market cap
- $345.89M
- SEC CIK
- 0002023016
- Latest annual report
- 10-K · Mar 31, 2026
Companies similar to Turn Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INDPIndaptus Therapeutics Inc. | 2.57 | +8.28% | $341.77M | vs TTRX |
| EBSEmergent BioSolutions Inc. | 6.94 | +1.91% | $355.84M | vs TTRX |
| ENTAEnanta Pharmaceuticals Inc. | 12.27 | +1.36% | $357.22M | vs TTRX |
| CYPHCypherpunk Technologies Inc. | 3.09 | +9.79% | $332.45M | vs TTRX |
| RLMDRelmada Therapeutics Inc. | 3.51 | +10.73% | $374.41M | vs TTRX |
| GALTGalectin Therapeutics Inc. | 3.75 | +3.02% | $378.19M | vs TTRX |
| PRLDPrelude Therapeutics Incorporated | 3.90 | +0.52% | $311.23M | vs TTRX |
| BNTCBenitec Biopharma Inc. | 8.86 | +1.26% | $309.06M | vs TTRX |